文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

异质性肾损伤生物标志物产生揭示人类脓毒症相关急性肾损伤亚型

Heterogenous Renal Injury Biomarker Production Reveals Human Sepsis-Associated Acute Kidney Injury Subtypes.
PubMed 文献 · Crit Care Explor · 2019-10-14
一句话结论脓毒症相关急性肾损伤患者肾活检中中性粒细胞明胶酶相关脂质运载蛋白与肾损伤分子-1表达异质且无相关性,提示该综合征存在多种病理生理亚型。

该研究采用前瞻性临床实验室设计,利用ICU脓毒症死亡患者的「温热」尸检肾活检与肿瘤肾切除对照肾组织,通过逆转录定量聚合酶链反应和免疫组化定量中性粒细胞明胶酶相关脂质运载蛋白与肾损伤分子-1的信使RNA和蛋白表达。结果显示脓毒症相关急性肾损伤患者肾组织中两者信使RNA和蛋白水平较对照升高,中性粒细胞明胶酶相关脂质运载蛋白定位于远端小管、集合管、肾小动脉外膜及肾小球簇,肾损伤分子-1定位于近端小管刷状缘。两者水平无相关性,且与肾损伤程度、危重程度或ICU入院及死亡当日血清肌酐水平均无关;激光显微切割肾小球后发现肾小球中性粒细胞明胶酶相关脂质运载蛋白产生异质性。作者认为满足急性肾损伤与脓毒症定义的患者可基于病理生理特征分为亚型。

要点

  • 脓毒症相关急性肾损伤患者肾组织中中性粒细胞明胶酶相关脂质运载蛋白与肾损伤分子-1的信使RNA和蛋白水平均较对照肾组织升高。
  • 中性粒细胞明胶酶相关脂质运载蛋白定位于远端小管、集合管、肾小动脉外膜及肾小球簇,肾损伤分子-1定位于近端小管刷状缘。
  • 中性粒细胞明胶酶相关脂质运载蛋白与肾损伤分子-1水平之间无相关性。
  • 肾中性粒细胞明胶酶相关脂质运载蛋白与肾损伤分子-1水平均与肾损伤程度、危重程度或ICU入院及死亡当日血清肌酐水平无关。
  • 激光显微切割肾小球后逆转录定量聚合酶链反应发现脓毒症相关急性肾损伤患者肾小球中性粒细胞明胶酶相关脂质运载蛋白产生异质性。

适用人群与场景

  • ICU中死于脓毒症的成人患者尸检肾活检组织;对照为接受肿瘤肾切除术的患者肾组织。

研究设计与关键结果

  • 研究类型为前瞻性临床实验室研究,使用「温热」人类尸检脓毒症相关急性肾损伤肾活检;样本量、中心数原文未报告。
  • 脓毒症相关急性肾损伤患者肾组织中中性粒细胞明胶酶相关脂质运载蛋白与肾损伤分子-1的信使RNA和蛋白水平较对照肾组织升高。
  • 中性粒细胞明胶酶相关脂质运载蛋白定位于远端小管、集合管、肾小动脉外膜及肾小球簇;肾损伤分子-1定位于近端小管刷状缘。
  • 中性粒细胞明胶酶相关脂质运载蛋白与肾损伤分子-1水平之间无相关性。
  • 肾中性粒细胞明胶酶相关脂质运载蛋白与肾损伤分子-1水平均与肾损伤程度、危重程度或ICU入院及死亡当日血清肌酐水平无关。
  • 激光显微切割肾小球后逆转录定量聚合酶链反应发现脓毒症相关急性肾损伤患者肾小球中性粒细胞明胶酶相关脂质运载蛋白产生异质性。

证据类型、等级与局限

  • 证据类型:前瞻性临床实验室研究(使用人类尸检肾活检与肾切除对照组织)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,满足急性肾损伤与脓毒症定义的患者可基于病理生理特征分为亚型。
  • 作者认为,脓毒症相关急性肾损伤不存在单一通路,存在多种不同病理生理途径。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: To identify mechanisms associated with sepsis-acute kidney injury based on the expression levels of renal injury biomarkers, neutrophil gelatinase-associated lipocalin, and kidney injury molecule-1 in renal biopsies which may allow the identification of sepsis-acute kidney injury patient subtypes.

DESIGN: Prospective, clinical laboratory study using "warm" human postmortem sepsis-acute kidney injury kidney biopsies.

SETTING: Research laboratory at university teaching hospital.

SUBJECTS: Adult patients who died of sepsis in the ICU and control patients undergoing tumor nephrectomy.

MEASUREMENTS AND MAIN RESULTS: Reverse transcription quantitative polymerase chain reaction and immunohistochemical staining were used to quantify messenger RNA and protein expression levels of neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in the kidney of sepsis-acute kidney injury patients and control subjects. Morphometric analysis was used to quantify renal and glomerular neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 protein levels. Neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 messenger RNA and protein levels were increased in kidneys of sepsis-acute kidney injury patients compared with control kidney tissue. Neutrophil gelatinase-associated lipocalin was localized in the distal tubules, collecting ducts, the adventitia of the renal arterioles, and in the glomerular tufts of renal biopsies from sepsis-acute kidney injury patients. In contrast, kidney injury molecule-1 was localized at the brush border of the proximal tubules. There was no correlation between neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 levels. Furthermore, renal neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 levels were not associated with the extent of renal injury, the severity of critical illness, or serum creatinine levels at either ICU admission or day of expiration. By laser microdissecting glomeruli, followed by reverse transcription quantitative polymerase chain reaction, we identified heterogenous glomerular neutrophil gelatinase-associated lipocalin production in the kidney of sepsis-acute kidney injury patients.

CONCLUSION: We found differences in the expression of neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with the same syndrome "sepsis-acute kidney injury" meaning there is no single pathway leading to sepsis-acute kidney injury. This underscores the beliefs that there are many/different pathophysiological pathways that can cause sepsis-acute kidney injury. Hence, patients with criteria that meet the definitions of both acute kidney injury and sepsis can be divided into subtypes based on pathophysiological features.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Jou-Valencia D, Koeze J, Popa ER, et al. Heterogenous Renal Injury Biomarker Production Reveals Human Sepsis-Associated Acute Kidney Injury Subtypes. Crit Care Explor. 2019. PMID: 32166228. doi:10.1097/CCE.0000000000000047

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。